1. Viruses, cancer and non-self recognition
- Author
-
Umesh Kalathiya, Katarzyna Dziubek, Maria C. Tovar Fernandez, Alicja Sznarkowska, Ewa Maria Sroka, Robin Fåhraeus, Sara Mikac, and Monikaben Padariya
- Subjects
viruses ,Cell- och molekylärbiologi ,Immunology ,Evasion (network security) ,virus–host interactions ,major histocompatibility (MHC) class I ,Self recognition ,Computational biology ,Review ,Major histocompatibility complex ,General Biochemistry, Genetics and Molecular Biology ,viral persistence ,03 medical and health sciences ,0302 clinical medicine ,Immune system ,Neoplasms ,MHC class I ,medicine ,Animals ,Humans ,lcsh:QH301-705.5 ,Review Articles ,cancer immune evasion ,030304 developmental biology ,Immune Evasion ,0303 health sciences ,Cancer och onkologi ,biology ,General Neuroscience ,Histocompatibility Antigens Class I ,Cancer ,Immunology in the medical area ,medicine.disease ,Immune checkpoint ,lcsh:Biology (General) ,Virus Diseases ,030220 oncology & carcinogenesis ,Immunologi inom det medicinska området ,Cancer and Oncology ,Cancer cell ,biology.protein ,viral immune evasion ,Cell and Molecular Biology - Abstract
Virus–host interactions form an essential part of every aspect of life, and this review is aimed at looking at the balance between the host and persistent viruses with a focus on the immune system. The virus–host interaction is like a cat-and-mouse game and viruses have developed ingenious mechanisms to manipulate cellular pathways, most notably the major histocompatibility (MHC) class I pathway, to reside within infected cell while evading detection and destruction by the immune system. However, some of the signals sensing and responding to viral infection are derived from viruses and the fact that certain viruses can prevent the infection of others, highlights a more complex coexistence between the host and the viral microbiota. Viral immune evasion strategies also illustrate that processes whereby cells detect and present non-self genetic material to the immune system are interlinked with other cellular pathways. Immune evasion is a target also for cancer cells and a more detailed look at the interfaces between viral factors and components of the MHC class I peptide-loading complex indicates that these interfaces are also targets for cancer mutations. In terms of the immune checkpoint, however, viral and cancer strategies appear different.
- Published
- 2021